Related Experiment Videos
A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis
S Verardi1, C U Casciani, E Nicora
1General Surgery Clinics, II University, S. Eugenio Hospital, Roma.
Summary
Low molecular weight heparin (LMWH) like Fluxum demonstrated superior efficacy in preventing postoperative thromboembolic complications compared to standard heparin. LMWH also showed better tolerability with fewer injection site hematomas.
Area of Science:
- General Surgery
- Pharmacology
- Thrombosis Research
Background:
- Postoperative thromboembolic complications, including deep vein thrombosis and pulmonary embolism, pose significant risks.
- Prophylaxis against these complications is crucial in surgical patients.
Purpose of the Study:
- To compare the efficacy of low molecular weight (LMW) heparin (Fluxum) versus standard calcium heparin for preventing postoperative thromboembolic events.
- To assess the tolerability and safety profile of LMW heparin compared to standard heparin.
Main Methods:
- A multicentric study involving 610 patients across six Italian general surgery departments.
- Patients were randomized to receive either LMW heparin (Fluxum) or standard calcium heparin via subcutaneous injection.
- Outcomes measured included deep vein thrombosis, pulmonary embolism, and hemorrhagic complications.
Main Results:
- A lower incidence of deep vein thrombosis (3.2% vs. 6.3%) and pulmonary embolism (0.32% vs. 1%) was observed in the LMW heparin group.
- No serious hemorrhagic accidents were reported in either group.
- LMW heparin (Fluxum) exhibited better overall tolerability, with a reduced frequency of hematomas at injection and surgical wound sites.
Conclusions:
- Low molecular weight heparin (Fluxum) is more effective than standard calcium heparin in preventing postoperative thromboembolic complications.
- LMW heparin offers a favorable safety and tolerability profile for thromboprophylaxis in surgical patients.